PIRCHE

PIRCHE AG, headquartered in Berlin Germany, is the exclusive provider of the PIRCHE technology and related matching services. The company is offering these services through its web-based portal to its customers.

Up to now, the allocation of a suitable transplant for a patient (bone marrow as well as solid organs) has been primarily based on the so-called HLA Types (Human Leucocyte Antigenes). This group of genes is responsible for the expression of proteins on the surface of those human cells, which are responsible for the immune reactions between the patient and the transplant.

PIRCHE takes this approach further, going directly into the analysis of the amino acids, which are the building blocks of proteins. Sophisticated algorithms working on the company's proprietary CordMatch® IT-system are the background of this quantum leap in applied transplantation science.